Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.6.3 appears on the study page, replacing the previous v3.6.2, indicating a version update of the ClinicalTrials.gov record.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page displays a newer revision tag (v3.6.2) replacing the previous v3.6.0. This reflects a minor backend or template update rather than substantive changes to the study information.SummaryDifference0.0%

- Check38 days agoChange DetectedThe enrollment status now shows that the study is no longer looking for participants. The page adds guidance sections to help readers understand and participate, and the revision note updates to v3.6.0 with a formatting adjustment for the Intervention/Treatment heading.SummaryDifference0.4%

- Check45 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small platform update rather than a change to the study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision entry was updated to v3.5.4, replacing the former v3.5.3 entry. This indicates a minor update to the page's revision history.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov release/revision number (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.